Statistics
Publications
1
Citations
174
H-Index
1
Active since
1993
Affiliations
National Cancer Institute(Current)
Michael Yanuck is an author at National Cancer Institute specializing in peptide epitopes, oncology, and tumor immunology.
Publications per year
1993–1993
1
1
A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells.
Michael Yanuck, D. Carbone, C D Pendleton et al. · PubMed · 1993 · 174 citations
Life Sciences, Immunology, Oncology +17
1–1 of 1